Search results
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Gateway - The Root
The Root· 54 minutes agoThe Biden administration is expected to announce this week that Americans who got the Pfizer-BioNTech or Moderna vaccines will need the third shot to protect themselves against ...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 4 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
Moderna develops combination COVID-19 and flu shot
WBAY Green Bay· 6 days agoModerna says the combination triggered a better immune response than the COVID-19 and flu shots alone.
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 6 days agoPharmaceutical company Moderna has announced that a combination vaccine it has been developing...
Moderna (NASDAQ:MRNA) Stock Price Down 2.2% on Insider Selling
ETF DAILY NEWS· 4 days agoShares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) traded down 2.2% during mid-day trading on Wednesday following insider selling activity. 392,597 shares changed hands ...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 6 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...